Israel - Inggeris - Ministry of Health

sanofi - aventis israel ltd - adenosine - solution for injection - adenosine 6 mg / 2 ml - adenosine - adenosine - rapid conversion to a normal sinus rhythm of paroxysmal supraventicular tachycardias including those associated with accessory bypass tracts (wolf parkinson-white syndrome).

Israel - Inggeris - Ministry of Health

sanofi - aventis israel ltd - levofloxacin as hemihydrate - solution for infusion - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

Israel - Inggeris - Ministry of Health

sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - docetaxel -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - risedronate sodium; calcium carbonate; colecalciferol; cholecalciferol -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - irbesartan -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - risedronate sodium; calcium carbonate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teriflunomide -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - allium sativum, quantity: 8.33 mg (equivalent: allium sativum, qty 100 mg); ascorbic acid, quantity: 500 mg; zinc gluconate, quantity: 14 mg (equivalent: zinc, qty 2 mg); echinacea purpurea, quantity: 22.22 mg (equivalent: echinacea purpurea, qty 1000 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; dl-alpha-tocopherol; garlic bulb powder; croscarmellose sodium; vanillin; maize starch; silicon dioxide; povidone; macrogol 400; hypromellose; magnesium stearate; microcrystalline cellulose; crospovidone - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support healthy immune system function ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; relieve symptoms of mild upper respiratory tract infections

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sevelamer hydrochloride -